Kala Bio Inc [KALA] stock is trading at $4.25, up 19.05%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The KALA shares have gain 44.31% over the last week, with a monthly amount drifted -29.75%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kala Bio Inc [NASDAQ: KALA] stock has seen the most recent analyst activity on March 30, 2022, when JP Morgan downgraded its rating to a Underweight. Previously, JP Morgan downgraded its rating to Neutral on August 06, 2021. On September 14, 2020, downgrade downgraded it’s rating to Hold but maintained its price target of $10 on the stock. Northland Capital started tracking the stock assigning a Outperform rating. H.C. Wainwright reiterated a Buy rating for this stock on May 27, 2020, and upped its price target to $17. In a note dated March 09, 2020, BofA/Merrill upgraded an Buy rating on this stock.
Kala Bio Inc [KALA] stock has fluctuated between $2.92 and $11.20 over the past year. Currently, Wall Street analysts expect the stock to reach $7.5 within the next 12 months. Kala Bio Inc [NASDAQ: KALA] shares were valued at $4.25 at the most recent close of the market. An investor can expect a potential return of 76.47% based on the average KALA price forecast.
Analyzing the KALA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.69, Equity is -3.89 and Total Capital is -1.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.62.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.49 points at the first support level, and at 2.73 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.02, and for the 2nd resistance point, it is at 5.79.
Ratios To Look Out For
For context, Kala Bio Inc’s Current Ratio is 3.11. Also, the Quick Ratio is 3.11, while the Cash Ratio stands at 3.02.
Transactions by insiders
Recent insider trading involved Kharabi Darius, CHIEF BUSINESS OFFICER, that happened on Jan 06 ’25 when 2021.0 shares were sold., Brazzell Romulus K completed a deal on Jan 06 ’25 to sell 2446.0 shares. Meanwhile, CHIEF EXECUTIVE OFFICER Iwicki Mark T sold 5779.0 shares on Jan 06 ’25.
